Skip to main content
. 2019 Oct 30;20(21):5403. doi: 10.3390/ijms20215403

Table 1.

Gene expression datasets used in this study.

Disease Datasets Platform Cases Controls References
MCI GSE63063
(GSE63060, GSE63061)		 Illumina GPL6947 80 104 [43,44,45]
MCI GSE63063
(GSE63060, GSE63061)		 Illumina GPL10558 109 136 [43,44,45]
ADD GSE63063
(GSE63060, GSE63061)		 Illumina GPL6947 142 104 [43,44,45]
ADD GSE63063
(GSE63060, GSE63061)		 Illumina GPL10558 139 136 [43,44,45]
ADD E-MTAB-6094 Agilent G4845A 22 13 Not published
AdvADD GSE97760 Agilent GPL16699 9 10 [46]

Blood transcriptomics studies selected for the analysis. * GSE63063 dataset are composed of two studies: GSE63060 and GSE63061. MCI: Mild cognitive impairment, ADD: Alzheimer’s disease dementia, AdvADD: Advanced Alzheimer’s disease dementia.